Hair Relaxer / Uterine Cancer Marketing & Claimant Acquisition

The litigation landscape

The hair relaxer litigation is consolidated as an MDL, with claims centered on lye and no-lye chemical relaxer products marketed and sold by major manufacturers — L'Oreal, Revlon, Soft Sheen-Carson, and Strength of Nature among them. Plaintiffs allege that repeated chemical exposure from these products is associated with uterine cancer, endometrial cancer, and ovarian cancer. The MDL structure means individual firms are actively building their dockets, and claimant acquisition is competitive but far from saturated.

Intake remains open, and the litigation is at a stage where firms that move now can accumulate case volume ahead of any significant docket-shaping developments. The injury profile — cancer diagnoses in women with documented relaxer use histories — creates a claimant pool that is motivated, identifiable, and responsive to direct-response social advertising when the messaging is handled with appropriate care and specificity.

Who a campaign targets

• Primary target audience: Women who used chemical hair relaxers (lye or no-lye) for five or more years and have been diagnosed with uterine or endometrial cancer — this profile represents the strongest case configuration a campaign should prioritize.
• Age targeting: Campaigns should weight toward women under 60, where the injury-to-exposure narrative tends to be most direct and case timelines most actionable.
• Secondary audience: Women with an ovarian cancer diagnosis and relaxer use history, or those with shorter documented use periods, may still warrant intake review — firms should define their own threshold for borderline profiles based on their docket strategy.
• Product identification: Claimants who can identify specific brand use (L'Oreal, Revlon, Soft Sheen-Carson, Strength of Nature) or recall consistent relaxer use over time are the most workable leads for intake teams.

How MTAA runs Hair Relaxer / Uterine Cancer campaigns

The creative strategy for hair relaxer campaigns lives at the intersection of product familiarity and health consequence. These are household-name brands used routinely over years or decades — the advertising challenge is not explaining what a relaxer is, but connecting a trusted, normalized product to a serious diagnosis the claimant may never have associated with it. MTAA builds ad creative that surfaces that connection plainly, without sensationalism, in a way that prompts women who recognize their own history to take the next step. Video and static formats both perform in this vertical; the most effective units lead with the cancer diagnosis and work backward to product use, rather than leading with the legal claim.

Audience construction on Meta leverages demographic and behavioral signals aligned with the target profile — women in the relevant age bands, with content affinities that correlate with relaxer use history. Because the claimant population skews toward Black women who have used these products culturally and consistently over long periods, creative and copy must reflect that lived experience authentically, not generically. Intake qualification questions are built into the lead flow to surface use duration and diagnosis type before a lead ever reaches your intake team, so your staff is spending time on pre-screened prospects rather than raw volume.